Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Breakthrough Gene Therapy Prevents Retinal Degeneration

Image on left shows damage (pink) to the retina. Image on right show that POD GDNF nanoparticles protected the retina from damage. (Image courtesy of Rajendra Kumar-Singh, Tufts University School of Medicine)
Image on left shows damage (pink) to the retina. Image on right show that POD GDNF nanoparticles protected the retina from damage. (Image courtesy of Rajendra Kumar-Singh, Tufts University School of Medicine)

Abstract:
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls. The study, published online in advance of print in Molecular Therapy, brings researchers closer to a non-viral gene therapy treatment for degenerative eye disorders.

Breakthrough Gene Therapy Prevents Retinal Degeneration

Boston, MA | Posted on August 16th, 2010

"Our work shows that it is possible to attain therapeutic results using non-viral gene delivery methods, specifically, nanoparticles. Nanoparticles, which are small enough to penetrate cells and stable enough to protect DNA, are capable of preventing retinal cell death and preserving vision," said senior author Rajendra Kumar-Singh, PhD, associate professor of ophthalmology at Tufts University School of Medicine (TUSM) and member of the genetics; neuroscience; and cell, molecular, and developmental biology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts.

"The most common approach to gene therapy involves using a virus to deliver DNA to cells. While viruses are very efficient carriers, they can prompt immune responses that may lead to inflammation, cancer, or even death. Non-viral methods offer a safer alternative, but until now, efficiency has been a significant barrier," said Kumar-Singh.

In a model simulating the progression of human retinal degeneration, the researchers treated mice with nanoparticles carrying a gene for GDNF (Glial Cell Line-Derived Neurotrophic Factor), a protein known to protect the photoreceptor cells in the eye. Retinas treated with the GDNF-carrying nanoparticles showed significantly less photoreceptor cell death than controls. Preservation of these cells resulted in significantly better eyesight in the treatment group seven days after treatment, compared to controls.

The protection conferred by the GDNF-carrying nanoparticles was temporary, as tests fourteen days after treatment showed no difference in eyesight between treated mice and controls.

"The next step in this research is to prolong this protection by adding elements to the DNA that permit its retention in the cell. Bringing forth a more potent and enduring result will move us closer to clinical application of non-viral gene therapy," said Kumar-Singh.

AMD, which results in a loss of sharp, central vision, is the number one cause of visual impairment among Americans age 60 and older. Retinitis pigmentosa, an inherited condition characterized by night blindness and loss of peripheral vision, affects approximately 1 in 4,000 individuals in the United States.

Additional authors on the study are first author Sarah Parker Read, an MD/PhD candidate at TUSM and Sackler and member of Kumar-Singh's lab, and Siobhan Cashman, PhD, research assistant professor in the department of ophthalmology at TUSM and member of Kumar-Singh's lab.

In a previous study, this same team of researchers developed the gene delivery method used in this research. The researchers showed that a peptide called PEG-POD, which compacts DNA into nanoparticles, delivers genes to the retina more efficiently than other non-viral carriers.

This study was supported by grants from The Ellison Foundation; the National Eye Institute, part of the National Institutes of Health; the Virginia B. Smith Trust; and grants to the Department of Ophthalmology at Tufts University from the Lions Eye Foundation and Research to Prevent Blindness. Sarah Parker Read is part of the Sackler/TUSM Medical Scientist Training Program, which is funded by the National Institute of General Medical Sciences, part of the National Institutes of Health.

Read SP, Cashman SM, Kumar-Singh R. Molecular Therapy. "POD Nanoparticles Expressing GDNF Provide Structural and Functional Rescue of Light-Induced Retinal Degeneration in an Adult Mouse." Published online August 10, 2010, doi: 10.1038/mt.2010.167

####

About Tufts University School of Medicine
Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts University are international leaders in innovative medical education and advanced research. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level. Ranked among the top in the nation, the School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical science.

For more information, please click here

Contacts:
Siobhan Gallagher
617-636-6586

Copyright © Tufts University School of Medicine

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Optimized method to detect high-dimensional entanglement December 3rd, 2021

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Two-dimensional bipolar magnetic semiconductors with high Curie-temperature and electrically controllable spin polarization realized in exfoliated Cr(pyrazine)2 monolayers December 3rd, 2021

Review on the femtosecond laser precision micro/nano-engineering December 3rd, 2021

Possible Futures

Researchers develop polyimide-mica nanocomposite film with high resistance to low earth orbit environments December 3rd, 2021

Researchers realize ultra-high precision search for exotic interactions December 3rd, 2021

Optimized method to detect high-dimensional entanglement December 3rd, 2021

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Academic/Education

Lifeboat Foundation Guardian Winner Jeff Bezos Donates One Million to Lifeboat Foundation Dream Project Winner Teachers in Space July 30th, 2021

NSF renews Rice-based NEWT Center for water treatment: Partnership primed to introduce game-changing technologies to address global needs October 15th, 2020

Matching Investment Program (MIP) Leverages $140K Empire State Development/NYSTAR Funding to SUNY Poly’s CATN2 to Enable $1.5M in Matching Commitments from Industry Partners: Investment Funds Faculty Research Related to Advanced Materials, Genomics, and Semiconductor Reliability October 18th, 2019

A Quantum Leap: $25M grant makes UC Santa Barbara home to the nation’s first NSF-funded Quantum Foundry, a center for development of materials for quantum information-based technologies September 16th, 2019

Nanomedicine

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Immune system-stimulating nanoparticle could lead to more powerful vaccines: The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases December 3rd, 2021

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Cancer cells use ‘tiny tentacles’ to suppress the immune system: With the power of nanotechnology, investigators have discovered that cancer cells strengthen by forming nanotubes that they use to suck mitochondria out of immune cells November 19th, 2021

Discoveries

Researchers develop polyimide-mica nanocomposite film with high resistance to low earth orbit environments December 3rd, 2021

Researchers realize ultra-high precision search for exotic interactions December 3rd, 2021

Optimized method to detect high-dimensional entanglement December 3rd, 2021

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Announcements

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Two-dimensional bipolar magnetic semiconductors with high Curie-temperature and electrically controllable spin polarization realized in exfoliated Cr(pyrazine)2 monolayers December 3rd, 2021

Review on the femtosecond laser precision micro/nano-engineering December 3rd, 2021

Development of a single-process platform for the manufacture of graphene quantum dots: Precisely controls the bonding configuration of heteroatoms in graphene quantum dots through simple chemical processes. Practical application and commercialization in various fields is expected December 3rd, 2021

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Light speed advances: UD Prof. Tingyi Gu receives DARPA Young Faculty Award December 3rd, 2021

Immune system-stimulating nanoparticle could lead to more powerful vaccines: The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases December 3rd, 2021

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Cancer cells use ‘tiny tentacles’ to suppress the immune system: With the power of nanotechnology, investigators have discovered that cancer cells strengthen by forming nanotubes that they use to suck mitochondria out of immune cells November 19th, 2021

Nanobiotechnology

Scientists edge closer to probe that would inspect atherosclerotic plaques by forcing molecules to sound their presence December 3rd, 2021

Immune system-stimulating nanoparticle could lead to more powerful vaccines: The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases December 3rd, 2021

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Cancer cells use ‘tiny tentacles’ to suppress the immune system: With the power of nanotechnology, investigators have discovered that cancer cells strengthen by forming nanotubes that they use to suck mitochondria out of immune cells November 19th, 2021

Research partnerships

Scientists develop promising vaccine method against recurrent UTI November 19th, 2021

Quantum brain sensors could be crucial in spotting dementia after University of Sussex scientists find they can track brain waves: Sensors introduce important new method to spot bio-marker for brain diseases • Accurate timings of when brain signals fire demonstrated for first tim November 19th, 2021

Quantum Collaboration: Two UCSB scientists receive award to partner with Cisco’s new Quantum Research Team November 3rd, 2021

A simple way to get complex semiconductors to assemble themselves: Much like crystallizing rock candy from sugar syrup, the new method grows 2D perovskites precisely layered with other 2D materials to produce crystals with a wide range of electronic properties September 17th, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project